Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Disc Medicine, Inc. Director's Dealing 2020

Aug 12, 2020

31589_dirs_2020-08-11_1d7b0be8-c6a7-4e55-961c-37bfd7524d8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FS Development Corp. (FSDC)
CIK: 0001816736
Period of Report: 2020-08-11

Reporting Person: FS Development Holdings, LLC (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Class B Common Stock $0 Class A Common Stock (3018750) Direct

Footnotes

F1: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.

F2: The shares of Class B common stock owned by the Reporting Person includes up to 393,750 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the issuer's securities do not exercise in full their over-allotment option as described in the issuer's registration statement.